Investment
Features
FeesSafety
Academy
More
Pluang+

Autohome to release Q3 2026 earnings on Nov 4, with a conference call for investors.

Company Fundamentals
14 Oct 2026
PRNewsWire
View Source
Neutral
Autohome to release Q3 2026 earnings on Nov 4, with a conference call for investors.

Autohome Inc., a leading online platform for automobile consumers in China, will announce its financial results for the third quarter ending September 30, 2026, on November 4 before U.S. markets open. The company will hold an earnings conference call at 7:00 AM U.S. Eastern Time (8:00 PM Beijing Time) the same day to discuss the results. Autohome provides extensive services for car buyers and sellers, including advertising, sales leads, and online transactions, making this report important for investors tracking China's auto market and digital commerce trends.

Autohome Inc. will announce its Q3 2026 financial results on November 4. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Oct 14, 2026 13:41 WIB: out of 134 US stocks, 86 rose and 39 fell. Notable movers include Aterian Inc (ATER) at USD 0.58 with a 1-day change of -4.56%, Amer Sports Inc (AS) at USD 29.53 up 4.09%, and Cheesecake Factory (CAKE) at USD 112.97 up 3.64%.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
1 hour ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
2 hours ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
2 hours ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
2 hours ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App